(Q36633987)

15 August 2017

1 reference

title

Established and evolving medical therapies for claudication in patients with peripheral arterial disease (English)

1 reference

15 August 2017

1 reference

Judith G. Regensteiner

series ordinal

1

object named as

Judith G Regensteiner

1 reference

15 August 2017

Kerry J Stewart

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Nature Clinical Practice Cardiovascular Medicine

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

604-610

1 reference

The prevalence of peripheral arterial disease in a defined population

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

Exercise in the treatment of claudication: assessment and treatment of functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

Exercise and intermittent claudication. Blood flow in the calf muscle during walking studied by the xenon-133 clearance method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

The US experience with cilostazol in treating intermittent claudication

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Current medical therapies for patients with peripheral arterial disease: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Peripheral arterial disease detection, awareness, and treatment in primary care

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Benefit of exercise conditioning for patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Exercise training improves functional status in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

European multicenter study on propionyl-L-carnitine in intermittent claudication.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Exercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Exercise for intermittent claudication.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Exercise training for claudication

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Intermittent claudication: is a supervised exercise class worth while?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Evaluation of walking capacity over time in 500 patients with intermittent claudication who underwent clinical treatment.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0660

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0660

1 reference

15 August 2017

1 reference